In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy (Q35977575)

11 August 2017

In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy (English)

1 reference

11 August 2017

1 reference

D W Siemann

1

1 reference

11 August 2017

K L Beyers

series ordinal

2

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 1993

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

68

1 reference

11 August 2017

6

1 reference

11 August 2017

1071-1079

1 reference

Glutathione metabolism as a determinant of therapeutic efficacy: a review

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

Combined effect of buthionine sulfoximine and cyclophosphamide upon murine tumours and bone marrow

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

Metabolism and reactions of alkylating agents

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

Enzymatic mechanisms of resistance to alkylating agents in tumor cells and normal tissues

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

Changes in cellular glutathione content during adriamycin treatment in human ovarian cancer--a possible indicator of chemosensitivity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

Glutathione modulation in cancer treatment: will it work?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

Reduction in glutathione content of L-PAM resistant L1210 Cells confers drug sensitivity.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

Heterogeneity in the radiation survival curves and biochemical properties of human lung cancer cell lines

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

Pharmacologic reversal of drug resistance in ovarian cancer.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumour agents shown by a range of human tumour cell lines.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

Prediction of tumour sensitivity to 4-hydroperoxycyclophosphamide by a glutathione-targeted assay

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

Thiol manipulation as a means of overcoming drug resistance in a novel cyclophosphamide-induced resistant cell line

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968664

An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions

11 July 2018

1 reference

12 December 2020

Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide

1 reference

12 December 2020

Selective modification of glutathione metabolism

1 reference

12 December 2020

The role of thiols in cellular response to radiation and drugs

1 reference

12 December 2020

Glutathione depletion in tissues after administration of buthionine sulphoximine

1 reference

12 December 2020

Altered mouse bone marrow glutathione and glutathione transferase levels in response to cytotoxins

1 reference

12 December 2020

Chemosensitization by buthionine sulfoximine in vivo

1 reference

12 December 2020

Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione

1 reference

12 December 2020

Comparison of glutathione levels in rodent and human tumor cells grown in vitro and in vivo

1 reference

12 December 2020

Glutathione contents in human and rodent tumor cells in various phases of the cell cycle

1 reference

12 December 2020

The effect of glutathione (GSH) depletion in vivo by buthionine sulfoximine (BSO) on the radiosensitization of SR 2508

1 reference

12 December 2020

In vivo modulation of glutathione by buthionine sulfoximine: effect on marrow response to melphalan

1 reference

12 December 2020

The growth of mouse bone marrow cells in vitro

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.484

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

8260357

1 reference